BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer
Metastasis is the leading cause of lung cancer-associated death. Downregulated expression of E-cadherin followed by epithelial-mesenchymal transition (EMT) is critical for metastasis initiation in lung cancer. BTBD7 plays essential roles in lung cancer metastasis, but the mechanisms remain unknown....
Main Authors: | Jie Shu, Lin Wang, Fei Han, Yubin Chen, Shunjun Wang, Fanyan Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2019/5937635 |
Similar Items
-
Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7
by: Jing-Si Wang, et al.
Published: (2020-01-01) -
TGF-β1-induced epithelial–mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin
by: Hui Wang, et al.
Published: (2017-11-01) -
Chlamydia trachomatis Infection Is Associated with E-Cadherin Promoter Methylation, Downregulation of E-Cadherin Expression, and Increased Expression of Fibronectin and α-SMA—Implications for Epithelial-Mesenchymal Transition
by: Jovana Rajić, et al.
Published: (2017-06-01) -
N-cadherin expression and epithelial mesenchymal transition in pancreatic carcinoma
by: Nakajima, Sanae
Published: (2011) -
The Mechanism of Thrombomodulin Downregulation in Epithelial-Mesenchymal Transition
by: Che-hsien Chu, et al.
Published: (2007)